Skip to main navigation
Skip to search
Skip to main content
Discovery - the University of Dundee Research Portal Home
Home
Profiles
Research units
Research Outputs
Projects
Datasets
Theses
Activity
Press/Media
Research Facilities
Prizes
Search by expertise, name or affiliation
Exacerbations of bronchiectasis
Alessandro De Angelis
, Emma D. Johnson
, Sivagurunathan Sutharsan
, Stefano Aliberti (Lead / Corresponding author)
Respiratory Medicine and Gastroenterology
Research output
:
Contribution to journal
›
Article
›
peer-review
27
Citations (Scopus)
141
Downloads (Pure)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Exacerbations of bronchiectasis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Bronchiectasis
100%
Stable State
66%
Homeostasis
33%
Multidisciplinary Approach
33%
Preventive Measures
33%
Pathophysiology
33%
Antibiotics
33%
Clinical Characteristics
33%
Economic Burden
33%
Insults
33%
Patient Outcomes
33%
Comorbidity
33%
Worse Outcome
33%
Airway
33%
Frequent Exacerbator
33%
Underlining
33%
Severity Assessment
33%
Clinical Heterogeneity
33%
Long-stay Patients
33%
Endogenous Factors
33%
Early Recognition
33%
Biomarker Research
33%
Treatment Measures
33%
Prompt Treatment
33%
Tailored Treatment
33%
Bronchiectasis Exacerbation
33%
Nonmicrobial
33%
Inflammatory Endotype
33%
State Phase
33%
Precision Medicine Research
33%
Precision Biomarkers
33%
Pollution Factor
33%
Exogenous Change
33%
Precise Recognition
33%
Island Model
33%
Endogenous Change
33%
Immunology and Microbiology
Homeostasis
100%
Prevalence
100%
Comorbidity
100%
Airway
100%
Biochemistry, Genetics and Molecular Biology
Homeostasis
100%
Prevalence
100%
Comorbidity
100%
Biomarker Research
100%
Medicine and Dentistry
Bronchiectasis
100%
Prevalence
25%
Infection
25%
Pathophysiology
25%
Homeostasis
25%
Biological Marker
25%
Personalized Medicine
25%
Endotype
25%
Comorbidity
25%
Nursing and Health Professions
Bronchiectasis
100%
Prevalence
25%
Treatment Outcome
25%
Infection
25%
Pathophysiology
25%
Biological Marker
25%
Personalized Medicine
25%
Comorbidity
25%
Pharmacology, Toxicology and Pharmaceutical Science
Bronchiectasis
100%
Biological Marker
25%
Pathophysiology
25%
Prevalence
25%
Infection
25%
Comorbidity
25%